Indications
ELIQUIS (apixaban) is a prescription
medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a prescription
medicine used in adults to treat blood clots in the veins of your legs (deep vein thrombosis-DVT) or lungs (pulmonary embolism-PE), and to reduce the risk of them occurring again after receiving treatment for blood clots.
ELIQUIS (apixaban) is a prescription
medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a prescription
medicine used in adults to help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of people who have just had hip or knee replacement surgery.
Indications
ELIQUIS (apixaban) is a
prescription medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a
prescription medicine used in adults to treat blood clots in the veins of your legs (deep vein thrombosis-DVT) or lungs (pulmonary embolism-PE), and to reduce the risk of them occurring again after receiving treatment for blood clots.
ELIQUIS (apixaban) is
a prescription medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a
prescription medicine used in adults to help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of people who have just had hip or knee replacement surgery.
Do not stop taking ELIQUIS without talking to the healthcare provider who prescribed it to you.
If you stop taking ELIQUIS, you may have increased risk of forming a clot in your blood.
Talk to your healthcare provider before any surgery, medical, or dental procedures. Learn more below.
ELIQUIS may cause serious side effects, including:
Bleeding
ELIQUIS can cause bleeding, which can be serious, and may lead to death. This is because ELIQUIS is a blood thinner medicine that reduces blood clotting. While taking ELIQUIS, you may bruise more easily and it may take longer than usual for any bleeding to stop. Be sure to seek medical attention right away if you have signs or symptoms of bleeding, such as unexpected bleeding or bruising, or bleeding that lasts a long time. You may have a higher risk of bleeding if you take blood thinners and take other medicines that increase your risk of bleeding. See below for more comprehensive information you should be aware of about bleeding and ELIQUIS.
Spinal or epidural blood clots (hematoma)
People who take ELIQUIS, and have medicine injected into their spinal and epidural area, or have a spinal puncture, have a risk of forming a blood clot that can cause long-term or permanent loss of the ability to move (paralysis). Learn more about the risk of developing an epidural blood clot while taking ELIQUIS.
Do not take ELIQUIS if you:
These are not all of the possible side effects of ELIQUIS. Call your healthcare provider for medical advice about side effects.
See below for more important safety information about ELIQUIS.
Talking With Your Doctor
Get tips from a nurse for talking with a doctor and download a discussion guide to help you make the most of your time with your healthcare professional.
About DVT/PE
Learn how a deep vein thrombosis (DVT) blood clot can lead to a pulmonary embolism (PE), and the role of ELIQUIS to treat DVT/PE and reduce the risk of them happening again.
About ELIQUIS
Find out more about ELIQUIS, including clinical study results, possible side effects, and additional factors for you and your healthcare professional to consider.